The hearing of a neuromass (former neuroplasma) is a benign tumour originating from the eighth pair of neural tumours, mostly from the frontal neurological. The neoplasm accounts for 8-10 per cent of the tumours in the skull, 80-90 per cent of the tumours in the small brain, most of them among adults aged 30-60 years, with a male-to-female ratio of 2:3 and an annual increase of 2.28 per 100,000 per year, thanks to advances in diagnostic methods. Most of them are single-sided, and very rare on both sides. The growth of tumours is generally slow, increasing by an average of 0.25 – 0.4 cm per month, with individual tumours increasing by 2 cm within one year.
Listen to the clinical signs of a neuromagnosis.
The clinical performance of the neuromagnosis is complex and its symptoms are not fully consistent and can be weighed, mainly because of the origin of the tumor, growth rate, direction, tumour size, blood supply, and cystic variability. The initial symptoms of hearing a nervous tumor are one-sided deafness and acoustic ringing, with most cases having an ear ringing, a high frequency sound, which is described as “blowing”, “sitting”, “beeping”, “beeping” etc. The sounds of the ears sometimes change, and for some time they disappear.
The sound can be intermittent or continuous. The atypical symptoms include headaches, sullimentation, dizziness and movement instability. The increase in late-stage tumours can oppress brain stem or cause intracranial stress, and failure to provide timely surgical intervention can threaten the life of the patient. As a result, when patients whose ears and hearing have been reduced come to the hospital, further visual screening is required to exclude the possibility of hearing neuromagnosis if the drug treatment is ineffective.
Surgery is the only effective way to treat a nervous tumor! Clinically, in the absence of apparent surgical taboos, patients are generally advised to perform early surgery to avoid a loss of hearing that is difficult to recover! Therefore, it is important that patients do not resist surgery, which is in the interest of maintaining hearing. Addressing the problem of surgical trauma and the risks of surgery that patients’ friends are worried about, in fact, with the development of medical imaging, microneurological surgery, and cranial neuropsytic monitoring, which, in addition to increasing the rate of expediency, has led to an increased focus on the preservation of the neurological function and the maintenance of the quality of life after surgery, especially the protection of the facial neurons, is an important factor to be considered first and foremost by cranial surgeons and most patients in their choice of treatment.
With the development of neurological physiology and microcircle neuromonitoring techniques, the entire hearing procedure can be performed under facial neurons. In order to avoid further damage to the facial nerve, the cynic surgeon’s operational proficiency in separating the tumor from the facial nerve can also have an impact on the post-operative neurological function of the patient.
The following should be done: 1 , sharp separation; 2 , towing tumours rather than facial neurons; 3 , not excessive tow neurological neurons; 4 , protection of blood from the neurological surroundings; 5 , avoidance of heat damage from electrocondensation.
A reminder.
If early symptoms, such as the sound of the ear and the loss of hearing, are given sufficient attention, are promptly referred to, early detection of early treatment, the damage to patients from the disease of hearing neuromagnosis will be significantly reduced and the story of the Koreans will not be repeated. More than that, if we can have some knowledge of brain diseases, value our own body changes, have access to timely medical care and make early diagnosis and treatment, most of them will no longer be terrible.
